断断续续 发表于 2025-3-26 21:44:43
Guangyuan Wang,Yuhui Du,Tingjian Chenctive metabolites. Liver toxicity is a challenging issue and a frequent cause of failure during drug development. In particular, drug-induced bile duct injury is a side effect of several drugs and dietary supplements, that can be either easy to manage and characterized by a good outcome, or mostly ularder 发表于 2025-3-27 03:30:59
http://reply.papertrans.cn/29/2814/281315/281315_32.png消音器 发表于 2025-3-27 08:48:44
https://doi.org/10.1007/978-3-030-02625-7hepatic manifestations of ALGS, illustrates the modalities and the criteria needed for diagnosis, describes the cornerstones of disease management, and discusses unresolved questions and clinical challenges.Mendicant 发表于 2025-3-27 09:28:19
http://reply.papertrans.cn/29/2814/281315/281315_34.png臭名昭著 发表于 2025-3-27 13:53:28
http://reply.papertrans.cn/29/2814/281315/281315_35.pngGudgeon 发表于 2025-3-27 20:58:08
http://reply.papertrans.cn/29/2814/281315/281315_36.pngtenuous 发表于 2025-3-27 23:20:32
Low Phospholipid-Associated Cholelithiasis (LPAC)n. . mutations have been described in up to 50% of cases. Ursodeoxycholic acid is the long-term treatment; cholecystectomy is indicated in the case of symptomatic gallstones. Hepato-biliary malignancy is a very rare event. Patients with end-stage liver disease may be candidates for liver transplantation.GLOOM 发表于 2025-3-28 03:25:18
Inflammatory Cholangitistis has evolved radically over the past century, moving from a purely surgical approach to an endoscopic one. Endoscopic retrograde cholangiopancreatography (ERCP) is currently the treatment of choice to establish biliary drainage and often to remove gallstones.Exuberance 发表于 2025-3-28 06:20:07
http://reply.papertrans.cn/29/2814/281315/281315_39.png思考而得 发表于 2025-3-28 12:32:51
cholestatic liver diseases.Includes special topics like bili.This book provides a comprehensive overview of the diagnosis and management of diseases of the biliary tree. Topics covered include: congenital biliary abnormalities, genetic cholangiopathies, autoimmune cholangiopathies, inflammatory and